809 related articles for article (PubMed ID: 20832749)
1. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.
Wang JB; Erickson JW; Fuji R; Ramachandran S; Gao P; Dinavahi R; Wilson KF; Ambrosio AL; Dias SM; Dang CV; Cerione RA
Cancer Cell; 2010 Sep; 18(3):207-19. PubMed ID: 20832749
[TBL] [Abstract][Full Text] [Related]
2. Rho GTPases and their roles in cancer metabolism.
Wilson KF; Erickson JW; Antonyak MA; Cerione RA
Trends Mol Med; 2013 Feb; 19(2):74-82. PubMed ID: 23219172
[TBL] [Abstract][Full Text] [Related]
3. The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy.
Lukey MJ; Greene KS; Erickson JW; Wilson KF; Cerione RA
Nat Commun; 2016 Apr; 7():11321. PubMed ID: 27089238
[TBL] [Abstract][Full Text] [Related]
4. Glutaminase: a hot spot for regulation of cancer cell metabolism?
Erickson JW; Cerione RA
Oncotarget; 2010 Dec; 1(8):734-40. PubMed ID: 21234284
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies impacting cancer cell glutamine metabolism.
Lukey MJ; Wilson KF; Cerione RA
Future Med Chem; 2013 Sep; 5(14):1685-700. PubMed ID: 24047273
[TBL] [Abstract][Full Text] [Related]
6. Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells.
Stalnecker CA; Ulrich SM; Li Y; Ramachandran S; McBrayer MK; DeBerardinis RJ; Cerione RA; Erickson JW
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):394-9. PubMed ID: 25548170
[TBL] [Abstract][Full Text] [Related]
7. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
Jeay S; Pianetti S; Kagan HM; Sonenshein GE
Mol Cell Biol; 2003 Apr; 23(7):2251-63. PubMed ID: 12640111
[TBL] [Abstract][Full Text] [Related]
8. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
[TBL] [Abstract][Full Text] [Related]
9. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
10. Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases.
Shutes A; Onesto C; Picard V; Leblond B; Schweighoffer F; Der CJ
J Biol Chem; 2007 Dec; 282(49):35666-78. PubMed ID: 17932039
[TBL] [Abstract][Full Text] [Related]
11. Identification of TRIO-GEFD1 chemical inhibitors using the yeast exchange assay.
Blangy A; Bouquier N; Gauthier-Rouvière C; Schmidt S; Debant A; Leonetti JP; Fort P
Biol Cell; 2006 Sep; 98(9):511-22. PubMed ID: 16686599
[TBL] [Abstract][Full Text] [Related]
12. Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation.
Saito S; Liu XF; Kamijo K; Raziuddin R; Tatsumoto T; Okamoto I; Chen X; Lee CC; Lorenzi MV; Ohara N; Miki T
J Biol Chem; 2004 Feb; 279(8):7169-79. PubMed ID: 14645260
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases.
Berenjeno IM; Núñez F; Bustelo XR
Oncogene; 2007 Jun; 26(29):4295-305. PubMed ID: 17213802
[TBL] [Abstract][Full Text] [Related]
14. Rho GTPases: promising cellular targets for novel anticancer drugs.
Fritz G; Kaina B
Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
[TBL] [Abstract][Full Text] [Related]
15. RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression.
Bozza WP; Zhang Y; Hallett K; Rivera Rosado LA; Zhang B
Oncotarget; 2015 Oct; 6(32):32723-36. PubMed ID: 26416248
[TBL] [Abstract][Full Text] [Related]
16. Biomolecular Interaction Assays Identified Dual Inhibitors of Glutaminase and Glutamate Dehydrogenase That Disrupt Mitochondrial Function and Prevent Growth of Cancer Cells.
Zhu M; Fang J; Zhang J; Zhang Z; Xie J; Yu Y; Ruan JJ; Chen Z; Hou W; Yang G; Su W; Ruan BH
Anal Chem; 2017 Feb; 89(3):1689-1696. PubMed ID: 28208301
[TBL] [Abstract][Full Text] [Related]
17. Conditions for activity of glutaminase in kidney mitochondria.
Kovacević Z; McGivan JD; Chappell JB
Biochem J; 1970 Jun; 118(2):265-74. PubMed ID: 5530189
[TBL] [Abstract][Full Text] [Related]
18. Role of Rho GTPases in breast cancer.
Tang Y; Olufemi L; Wang MT; Nie D
Front Biosci; 2008 Jan; 13():759-76. PubMed ID: 17981586
[TBL] [Abstract][Full Text] [Related]
19. Rho GTPase expression in tumourigenesis: evidence for a significant link.
Gómez del Pulgar T; Benitah SA; Valerón PF; Espina C; Lacal JC
Bioessays; 2005 Jun; 27(6):602-13. PubMed ID: 15892119
[TBL] [Abstract][Full Text] [Related]
20. Influencing cellular transformation by modulating the rates of GTP hydrolysis by Cdc42.
Fidyk N; Wang JB; Cerione RA
Biochemistry; 2006 Jun; 45(25):7750-62. PubMed ID: 16784226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
